1. A new prognostic model including platelet/lymphocyte ratio and International Prognostic Score 3 for freedom from progression in patients with previously untreated advanced classical Hodgkin lymphoma. Issue 5 (3rd March 2022) Authors: Tao, Yunxia; Chen, Haizhu; Zhou, Yu; He, Xiaohu; Qin, Yan; Liu, Peng; Zhou, Shengyu; Yang, Jianliang; Zhou, Liqiang; Zhang, Changgong; Yang, Sheng; Gui, Lin; Shi, Yuankai Journal: Asia-Pacific journal of clinical oncology Issue: Volume 18:Issue 5(2022) Page Start: e486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I study of FCN-411, a pan-HER inhibitor, in EGFR-mutated advanced NSCLC after progression on EGFR tyrosine kinase inhibitors. (April 2022) Authors: Lin, Lin; Pan, Hongming; Li, Xingya; Zhao, Chengling; Sun, Jiangtao; Hu, Xingsheng; Zhang, Yiping; Wang, Mengzhao; Ren, Xiubao; Luo, Xiaoyong; Shan, Guoyong; Hui, Ai-Min; Wu, Zhuli; Liu, Huilong; Tian, Ling; Shi, Yuankai Journal: Lung cancer Issue: Volume 166(2022) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma. Issue 7 (July 2015) Authors: Yang, Jianliang; Shi, Yuankai; He, Xiaohui; Dong, Mei; Zhang, Changgong; Liu, Peng; Zhou, Shengyu; Qin, Yan; Gui, Lin; Yang, Sheng; Sun, Yan Journal: Leukemia & lymphoma Issue: Volume 56:Issue 7(2015:Jul.) Page Start: 2218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A prognostic model for platinum‐doublet as second‐line chemotherapy in advanced non‐small‐cell lung cancer patients. (19th March 2016) Authors: Mo, Hongnan; Hao, Xuezhi; Liu, Yutao; Wang, Lin; Hu, Xingsheng; Xu, Jianping; Yang, Sheng; Xing, Puyuan; Shi, Youwu; Jia, Bo; Wang, Yan; Li, Junling; Wang, Hongyu; Wang, Ziping; Sun, Yan; Shi, Yuankai Journal: Cancer medicine Issue: Volume 5:Number 6(2016:Jun.) Page Start: 1116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A prognostic nomogram constructed for relapsed or refractory diffuse large B‐cell lymphoma patients. Issue 2 (1st July 2019) Authors: Jiang, Shiyu; Qin, Yan; Liu, Peng; Yang, Jianliang; Yang, Sheng; He, Xiaohui; Zhou, Shengyu; Gui, Lin; Zhang, Changgong; Zhou, Liqiang; Sun, Yan; Shi, Yuankai Journal: Asia-Pacific journal of clinical oncology Issue: Volume 18:Issue 2(2022) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Prospective Study of Apatinib in Patients with Extensive‐Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy. (6th April 2020) Authors: Liu, Yutao; Hu, Xingsheng; Jiang, Jun; Yang, Lin; Zhou, Shengyu; Liu, Peng; Li, Junling; Wang, Yan; Hao, Xuezhi; Shi, Yuankai Journal: Oncologist Issue: Volume 25:Number 5(2020) Page Start: e833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Absolute monocyte count is a prognostic indicator in a patient with diffuse large B-cell lymphoma after autologous peripheral blood stem cell transplant. Issue 2 (February 2015) Authors: Mo, Hongnan; Shi, Yuankai; Han, Xiaohong; Zhou, Shengyu; He, Xiaohui; Liu, Peng; Yang, Jianliang; Zhang, Changgong; Yang, Shen; Qin, Yan; Gui, Lin; Shi, Youwu; Yao, Jiarui; Zhao, Liya; Zhang, Shuxiang Journal: Leukemia & lymphoma Issue: Volume 56:Issue 2(2015:Feb.) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial. Issue 5 (May 2016) Authors: Park, Keunchil; Tan, Eng-Huat; O'Byrne, Ken; Zhang, Li; Boyer, Michael; Mok, Tony; Hirsh, Vera; Yang, James Chih-Hsin; Lee, Ki Hyeong; Lu, Shun; Shi, Yuankai; Kim, Sang-We; Laskin, Janessa; Kim, Dong-Wan; Arvis, Catherine Dubos; Kölbeck, Karl; Laurie, Scott A; Tsai, Chun-Ming; Shahidi, Mehdi; Kim... Journal: Lancet oncology Issue: Volume 17:Issue 5(2016:May) Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Anti‐p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta‐analysis. (10th November 2019) Authors: Liu, Shuxia; Tan, Qiaoyun; Song, Yuanyuan; Shi, Yuankai; Han, Xiaohong Journal: Scandinavian journal of immunology Issue: Volume 91:Number 2(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Autologous peripheral blood stem cell mobilization following dose‐adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high‐risk non‐Hodgkin's lymphoma. Issue 3 (14th September 2015) Authors: Shi, Yuankai; Zhou, Ping; Han, Xiaohong; He, Xiaohui; Zhou, Shengyu; Liu, Peng; Yang, Jianliang; Zhang, Changgong; Gui, Lin; Qin, Yan; Yang, Sheng; Zhao, Liya; Yao, Jiarui; Zhang, Shuxiang Journal: Cancer communications Issue: Volume 34:Issue 3(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗